Good morning :)
Dev Labtech Venture Ltd

Dev Labtech Venture Ltd

DEVLAB Share Price

BSE
₹24.506.49% (-1.70)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

With a market cap of ₹153 cr, stock is ranked 2,941

Stock is 5.54x as volatile as Nifty

DEVLAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹153 cr, stock is ranked 2,941

Stock is 5.54x as volatile as Nifty

DEVLAB Performance & Key Metrics

DEVLAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
—3.01—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.185.540.51%

DEVLAB Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

DEVLAB Company Profile

Dev Labtech Venture Limited manufactures polished and lab-grown diamonds using MPCVD technology, serving industries like mining and oil with products such as CVD diamonds for industrial tools.

DEVLAB Similar Stocks (Peers)

Compare with peers Compare with peers 

DEVLAB Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
58.43
58.43
1Y Return
4.57%
4.57%
Buy Reco %
86.67
86.67
PE Ratio
94.70
94.70
1Y Return
6.23%
6.23%
Buy Reco %
66.67
66.67
PE Ratio
57.09
57.09
1Y Return
32.54%
32.54%
Buy Reco %
83.33
83.33
PE Ratio
151.44
151.44
1Y Return
9.13%
9.13%
Buy Reco %
91.67
91.67
PE Ratio
53.37
53.37
1Y Return
30.76%
30.76%
Buy Reco %
90.00
90.00
Compare with Peers

DEVLAB Forecast

DEVLAB Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

DEVLAB

DEVLAB

Income

Balance Sheet

Cash Flow

DEVLAB Income Statement

DEVLAB Income Statement

Loading...

Hmm, looks like data is unavailable here. Please come back after some time

DEVLAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
 

DEVLAB Stock Peers

DEVLAB Past Performance & Peer Comparison

DEVLAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dev Labtech Venture Ltd16.013.01—
Apollo Hospitals Enterprise Limited58.4311.370.25%
Manipal Health Enterprises Limited94.709.60—
Max Healthcare Institute Limited57.097.660.24%
ScreenerCompare valuation on Screener

DEVLAB Stock Price Comparison

Compare DEVLAB with any stock or ETF
Compare DEVLAB with any stock or ETF
DEVLAB
Loading...

DEVLAB Holdings

DEVLAB Shareholdings

DEVLAB Promoter Holdings Trend

DEVLAB Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

DEVLAB Institutional Holdings Trend

DEVLAB Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

DEVLAB Shareholding Pattern

DEVLAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding56.69%0.00%0.00%0.00%43.31%

Sep 2025

Mar 2026

May 2026

Sep 2026

DEVLAB Shareholding History

DEVLAB Shareholding History

MarAprSepMarMaySep0.00%0.00%0.00%0.00%0.00%0.00%

DEVLAB Insider Trades & Bulk Stock Deals

DEVLAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing DEVLAB stock

smallcases containing DEVLAB stock

Looks like this stock is not in any smallcase yet.

DEVLAB Events

DEVLAB Events

DEVLAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

DEVLAB has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

DEVLAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

DEVLAB has not given any dividends in last 5 years

DEVLAB Dividends

DEVLAB Dividends

Hmm, looks like data is unavailable here. Please come back after some time

DEVLAB Stock News & Opinions

DEVLAB Stock News & Opinions

Corporate
Corporate
Dev Labtech Venture Limited receives certificate from MUFG Intime India Private Limited

Dev Labtech Venture Limited informed the BSE Limited that it has received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, its Registrar and Share Transfer Agent (RTA).

1 week agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited seeks shareholder approval for a preferential warrant allotment to investors

Dev Labtech Venture Limited is proceeding with a preferential allotment of warrants, which will be converted into equity shares, with allotment dates yet to be determined pending shareholder approval. The offering involves preferential allotment to Promoter/Director Jerambhai Lavjibhai Donda, Whole-Time Director/CFO Jay Jerambhai Donda (a relative), Director Dimple Jay Donda (also a relative), Practicing Company Secretary Ricky Kapadia, and several non-promoter investors including Sachin Madhusudan Chhatre and Rajendrasinh Hathisinh Sarvaiya. Allottees will pay 25% of the consideration upon warrant allotment and the remaining 75% upon equity share conversion, with any unutilized funds forfeited if conversion doesn't occur within 18 months. The equity shares resulting from the warrant conversion will be listed on the BSE SME Platform and are subject to SEBI lock-in regulations, while a valuation report from Ricky Kapadia was used to determine the warrant price.

1 week agoCapital Market - Live
Spotlight
Spotlight
Dev Labtech Venture Limited raises Rs 17.81 crore via preferential allotment of warrants

Dev Labtech Venture Limited announced a board decision to raise Rs 17.81 crore through the preferential allotment of up to 1,37,00,000 convertible warrants to promoter/promoter group and non-promoter shareholders at a price of Rs 13 per warrant, convertible into equity shares with a face value of Rs 5 each and a premium of Rs 8. The company also approved an increase in its authorized share capital from Rs 25 crore (divided into 5 crore equity shares of Rs 5 each) to Rs 31 crore (divided into 6,20,00,000 equity shares of Rs 5 each). Additionally, the board appointed Ricky Kapadia as the scrutinizer for the upcoming Extraordinary General Meeting (EGM) and fixed October 29, 2026, as the record date for e-voting eligibility.

2 weeks agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited authorized share capital increased to Rs 31 crore, issuing warrants to promoters

Dev Labtech Venture Limited increased its authorized share capital from Rs 25 crore divided into 5 crore equity shares of Rs 5 each to Rs 31 crore divided into 6.2 crore equity shares of Rs 5 each. The company also approved the issuance of up to 1.37 crore convertible warrants to promoters, promoter groups, and non-promoters on a preferential basis at a price of Rs 13 each, potentially raising Rs 17.81 crore. Additionally, the board appointed Ricky Kapadia as the scrutinizer for the upcoming Extraordinary General Meeting (EGM), scheduled for November 5, 2026, and fixed October 29, 2026, as the record date for e-voting eligibility.

2 weeks agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited’s board authorized a share capital increase and convertible warrant issuance

Dev Labtech Venture Limited said its board approved an increase in the authorized share capital from Rs 25 crore divided into 5 crore shares of Rs 5 each to Rs 31 crore divided into 6.2 crore shares of Rs 5 each. The board also approved the issuance of up to 13.7 million convertible warrants to promoters, promoter groups, and non-promoters on a preferential basis at a price of Rs 13 per warrant, potentially raising Rs 17.81 crore. The company has fixed October 29, 2026, as the record date for determining shareholders eligible to vote at an extraordinary general meeting scheduled for November 5, 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited to consider increasing share capital at October 7 meeting

Dev Labtech Venture Limited will hold a board meeting on Wednesday, October 7, 2026, at 3:00 p.m. to consider increasing the company’s authorized share capital and evaluating proposals for raising funds through the issue of equity shares or other convertible securities via a preferential allotment, subject to regulatory approvals. The company has also closed its trading window for insiders and designated persons from October 2, 2026, until 48 hours after the release of undisclosed price-sensitive information.

2 weeks agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited closes securities trading window ahead of financial results

Dev Labtech Venture Limited informed the BSE Limited that the trading window for dealing in securities of the company will be closed from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the half year ended September 30, 2026, in accordance with SEBI regulations.

3 weeks agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited secures Rs 210.00 lakh credit facilities from HDFC Bank

Dev Labtech Venture Limited has entered into a Master Facility Agreement with HDFC Bank on September 5, 2026, to avail credit facilities of Rs 210.00 lakh for working capital requirements. The facility, an Overdraft Against Property - Manufacturers (ODAP-MFRS), carries an interest rate of 8.9% per annum and has a tenure of 12 months, repayable on demand and subject to annual renewal, with primary security provided as residential and commercial property.

1 month agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited appointed a scrutinizer and e-voting platform for its AGM

Dev Labtech Venture Limited informed the BSE Limited that its Board of Directors approved the Directors’ Report for the financial year ended March 31, 2026, appointed Mr. Ricky Kapadia of M/s. RPK & Associates as Scrutinizer for the 33rd Annual General Meeting, and appointed National Securities Depository Limited for e-voting platform services, with a record date of September 19, 2026, for determining member eligibility to vote electronically at the 33rd Annual General Meeting scheduled for September 26, 2026, at 1:00 p.m. through video conferencing or other audio-visual means.

1 month agoCapital Market - Live
Corporate
Corporate
Dev Labtech Venture Limited's board approved Rs 2.10 crore in credit facilities from HDFC Bank

Dev Labtech Venture Limited informed the BSE that its board approved availing credit facilities of Rs 2.10 crore from HDFC Bank, and withdrew its earlier decision to strike off Dev Labtech Venture Inc. (USA), a wholly-owned subsidiary, citing present and future business requirements and strategic expansion plans.

2 months agoCapital Market - Live

Frequently asked questions

  1. The share price of DEVLAB as on 22nd October 2026 is ₹24.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Dev Labtech Venture Ltd (DEVLAB) share are
    • Past 1 week: -16.38%
    • Past 1 month: 17.11%
    • Past 3 months: 45.97%
    • Past 6 months: -4.62%
    • Past 1 year: 62.49%
    • Past 3 years: 57.51%
    • Past 5 years: 97.57%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dev Labtech Venture Ltd (DEVLAB) is ₹153.41 Cr as of 22nd October 2026.

  4. The 52-week high of Dev Labtech Venture Ltd (DEVLAB) is ₹33.99 and the 52-week low is ₹13.75.

  5. The P/E (price-to-earnings) ratio of Dev Labtech Venture Ltd (DEVLAB) is 16.01. The P/B (price-to-book) ratio is 3.01.

  6. Dev Labtech Venture Ltd (DEVLAB) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  7. You can directly buy Dev Labtech Venture Ltd (DEVLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.